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Abstract 
Foot problems are extremely common in patients with rheumatoid arthritis (RA). 
There is ample evidence that foot pain, either alone or as a comorbidity, contributes 
significantly to disability. Despite the high prevalence of foot disease in RA, this 
problem is often trivialised or underappreciated. The inequity in foot health provision 
for patients with rheumatic disorders in New Zealand has recently been highlighted. 
Expertise in dealing with foot problems is often limited among healthcare 
professionals, and it has been argued that better integration of podiatric services into 
rheumatology services would be beneficial. The aim of this paper is to highlight the 
major issues related to foot care for patients with arthritis and provide key 
recommendations that should implemented to improve access to podiatric services in 
New Zealand. 
A publication in the Journal of Foot and Ankle Research has highlighted the need for 
improved access to podiatry care for rheumatology patients in New Zealand.1 In 
summary, the clinical audit demonstrates that there is an unmet need for professional 
and specialist foot care and concurs with findings from an audit in the UK that also 
identified the same unmet need.2 Although these two studies were carried out in one 
locality, albeit different countries, it is perceived generally that the input of specialist 
podiatry into rheumatology services is, at best patchy. 
The rheumatoid foot 
Rheumatoid arthritis (RA) is the most common inflammatory arthritis. It is a chronic, 
immune-mediated inflammatory disease which can lead to significant joint damage 
and functional impairment.3 Up to 90% of people with RA have foot involvement and 
the prevalence and impact of foot problems is strongly associated with disease 
severity and duration.3 Medical management focuses mainly on controlling disease 
activity, providing symptom relief and maximising quality of life.  
Although modern treatments have improved systemic disease control substantially in 
recent years, complete remission is still unusual. However, despite the medical 
management patients often continue to suffer the effects of joint damage with the foot 
being affected in the majority of cases. 
People with RA often present at their consultation with complex needs, and it is easy 
for foot problems to be overlooked. Assessment of the feet is not as straightforward as 
more accessible parts of the body. Foot examination may be considered awkward by 
some practitioners as the footwear has to be removed. Where a foot assessment is 
performed, the management of foot problems is sometimes not well understood. The 
end result of this uncertainty and inconsistency is that foot problems are often 
neglected, and lack of integration of podiatry into the rheumatology team maintains it 
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as a Cinderella service and people with RA continue to suffer foot pain, limited 
ability and poor quality of life.4 
It is of concern that foot problems are overlooked as we know that the majority of 
patients have foot involvement. Patients with inflammatory arthritis have an increased 
need for a range of basic foot care services. Long-standing inflammation leads to 
structural deformity and soft tissue lesions which in turn generate areas of pressure 
that result in callus and corn formation (Figure 1). There is evidence that early 
intervention for existing or potential foot problems can improve long term outcomes.5 
Baseline foot examinations can identify people with existing or imminent needs and 
provide a comparator for assessment. Regular assessments that document the rate of 
structural change can aid treatment decisions and improves outcomes.4 
 
Figure 1. Rheumatoid foot with a severe bunion, lesser toe deformities and 
bursitis over the second and third metatarsal heads 
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Patients with RA who experience a sudden ‘flare’ in disease activity should have 
direct access to specialist advice, and be offered the option of an early review with 
appropriate multidisciplinary team members, including podiatrists. Similar reviews of 
needs should be undertaken during periods of disease remission. Podiatrists have a 
role to play in supporting patients with RA in managing aspects of their condition 
themselves, as well as in providing timely and relevant foot health specific advice and 
education.  
Patients with RA can experience variations in disease activity (exacerbations and 
remissions) and may have acute needs (e.g. infection) superimposed on the overall 
disease process.2 The foot contributes to difficulty with walking in about 75% of 
people with RA, and is the main or only cause of walking difficulty in 25%. In the 
foot, joint pain and stiffness is the most common initial presentation, but a range of 
other features, including tenosynovitis, nodule formation and tarsal tunnel syndrome 
may also present, reflecting widespread soft-tissue involvement. 3  
Podiatrists have a prominent role to play in symptom relief and improving quality of 
life because involvement of the feet, even to a mild degree, is a significant marker for 
impaired mobility, functional incapacity and negative psychosocial impact.4 In the 
UK, NICE have published the guidelines on the treatment of people with RA.6 These 
guidelines provide a clear information and direction to commissioners and providers 
on what is expected by NICE in terms of funding and service provision. NICE 
recommended that all people with RA and foot problems should have access to a 
podiatrist for assessment and periodic review of their foot health needs, and that foot 
orthoses and therapeutic footwear should be available for all people with RA if 
indicated.  
Current podiatric services and rheumatoid arthritis 
A scoping exercise led by the key author exploring regionalised access to podiatry 
services was carried out through the professional body, Podiatry New Zealand. The 
findings overall were a lack of consistency and integration with rheumatology 
services with aspects of podiatry being provided by a range of disciplines including 
consultants, medical trainees, general practitioners, nurses, orthotists, 
physiotherapists, and occupational therapists in addition to podiatrists when they are 
accessible. In comparison with diabetic foot care there is inequality.  
The New Zealand Guidelines Group published a minimum standard of guidelines for 
the assessment and monitoring of the diabetic foot in New Zealand.7 People with 
rheumatic diseases often present with complex needs, and it is easy for podiatric 
problems to be overlooked such as pain, functional activities and disability.  
However, there is published evidence of unmet podiatric care needs for patients with 
RA;8 evidence that single interventions such as orthotics and footwear are clinically 
effective;9,10 and evidence of UK-wide under provision of foot care either in primary 
or secondary care settings.11 Phase I and II data and the methodological 
considerations for a definitive phase III trial of podiatry-led care have recently been 
published.12 Recent review papers report moderate-to-good evidence for the use of 
foot orthoses in patients with rheumatoid arthritis.9,10,13 
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Current evidence from a New Zealand perspective has recently been reported.1The 
goal of the study was to identify the nature of foot problems experienced by patients 
with RA attending the rheumatology outpatient clinics at Counties Manukau DHB 
and to ascertain the availability of a podiatry services for these patients. Foot and 
ankle assessment were based upon the recommendations from the Standards of Care 
for People with Musculoskeletal Foot Health Problems.4  
100 patients (n=100) who fulfilled the American College of Rheumatology criteria for 
diagnosis of RA were recruited into the study.14 Patients were excluded if they did not 
fulfil American College of Rheumatology criteria for RA and non-residents/visitors 
with only brief contact with Counties Manukau DHB (< 3 months) or who lived 
outside Counties Manukau DHB.  
The results demonstrated over 85% of RA patients suffered from foot lesions, ranging 
from callus, corns and nail problems. 86% of patients had deformities of their lesser 
toes. The majority of foot lesions (64%) were observed on the forefoot around the 
metatarsal heads. Bilateral hallux valgus (bunions) was observed in 64% of patients.  
The current study highlighted that patients with RA at Counties Manukau DHB have 
an increased need for a range of podiatric interventions and preventions. The results 
also highlighted high number of patients with foot pain and disability associated with 
foot problems that includes callus, corns and lesser toe deformities with RA. 
Recommendations of the study included that baseline foot examination can identify 
people with existing or imminent needs and provide a comparator for assessment. 
Regular assessments that document the rate of structural change can aid treatment 
decisions and improves outcomes. An annual musculoskeletal, vascular and 
neurological assessment, which includes an assessment of the lower limbs and feet, 
will help identify problems early.  
Recommendations to improve access to podiatry services for 
New Zealand with rheumatoid arthritis 
Expertise in dealing with foot problems is often limited among rheumatologists and 
primary care practitioners, and it has been argued that better integration of podiatric 
services into rheumatology care would be beneficial. Last year, a foot and ankle 
symposium was held last year prior to the New Zealand Rheumatology Association 
conference which speakers from New Zealand and the UK presented the problems 
associated with the musculoskeletal foot and ankle. The key speakers included 
orthopaedic surgeons, rheumatologists, physiotherapists, podiatrists and specialist 
nurses. The conference was very well attended by a range of health care professionals 
and the need to develop and implement a rheumatology focussed foot and ankle 
interest group was agreed by all delegates.  
The recent work by our group1 further emphasises that this is an unmet need for 
patients with arthritis in New Zealand, and that incorporation into the rheumatology 
multidisciplinary team is required to improve clinical outcome of these patients. It 
was also clear from the discussions that ensued that what is needed is an integrated 
approach to the management of foot problems with podiatrists being the key 
practitioner in co-ordinating assessment and management of the foot and its related 
problems.  
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Future directions should include education and training should be provided to primary 
care staff and foot health care providers to enable them to understand the systemic 
consequences of musculoskeletal disorders on the feet. Training should begin with 
undergraduate education and extend to post-registration education and continuing 
professional development.4,15 
Clear guidelines, protocols and referral pathways should be developed locally that 
include agreed criteria for suitability for self-management, eligibility for access to 
foot health services from both primary and secondary care referrals, and also for self-
referral.  
Referral pathways in to podiatric services should make clear: 
• Who has access to their services (e.g. geographic location, referring agencies 
and organisations); 
• The signs and symptoms that indicate referral; 
• Red flags that indicate priority referral.4 Examples would include: joint pain 
and synovitis—within the first 18 months from onset of symptoms. Restricted 
mobility and activity limitation associated with the above or established foot 
disease. Inability to care for own feet; Risk factors for ulceration—deformity, 
vasculitis poor footwear, medication affecting tissue viability. Signs of 
infection (bacterial, fungal or viral) or ulceration (particularly those patients 
on biologics). 
Podiatrists should be fully integrated as a member of a multidisciplinary team. While 
some musculoskeletal foot problems can be managed in isolation, complex or 
systemic conditions such as RA require a multidisciplinary approach to 
management.16,17  
Foot disorders can affect many aspects of a person’s life, especially when associated 
with systemic disease, and care may need to include input from many different 
professionals from health and social care. Surgery may also be considered when 
severe symptoms persist and do not respond to conservative treatment. People with 
progressive foot problems may require specialist surgical opinion with the facility for 
immediate surgical referrals e.g. those with nerve compression or tendon ruptures.4 
In summary, we hope the recommendations suggested in this view-point will act as a 
catalyst for all stakeholders—service users, providers, commissioners and 
policymakers—to work together to implement access to their local podiatric services 
and crucially, to strive for integration of specialist podiatrists into the 
multidisciplinary team. 
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